Global Eliquis Market Size By Indication, By End-User, By Distribution Channel, By Geographic Scope And Forecast
Report ID: 458047|No. of Pages: 202
Global Eliquis Market Size By Indication, By End-User, By Distribution Channel, By Geographic Scope And Forecast
Eliquis Market Size And Forecast
Eliquis Market size was valued at USD 31.04 Billion in 2023 and is projected to reach USD 75.53 Billion by 2031, growing at a CAGR of 9.3% during the forecast period 2024 to 2031.
Global Eliquis Market Drivers
The Eliquis Market refers to the market for Eliquis, a prescription medication used for anticoagulation in various conditions, including atrial fibrillation, deep vein thrombosis, and pulmonary embolism. The market for Eliquis is influenced by several key drivers:
- Increasing Prevalence of Cardiovascular Diseases: Cardiovascular diseases, including atrial fibrillation and thromboembolic conditions, are on the rise globally. This increase drives demand for anticoagulants like Eliquis.
- Aging Population: As the global population ages, the incidence of conditions requiring anticoagulation therapy is expected to grow, thereby boosting the market for Eliquis.
- Shift from Warfarin to Direct Oral Anticoagulants (DOACs): With the growing preference for DOACs such as Eliquis over traditional anticoagulants like warfarin due to their ease of use, fewer dietary restrictions, and no need for regular monitoring, the market is benefiting.
- Clinical Evidence and Guidelines: Strong clinical trial data supporting the efficacy and safety of Eliquis, along with endorsements in clinical practice guidelines, enhance its adoption among healthcare providers.
- Increased Awareness and Diagnosis: Growing awareness of atrial fibrillation and other thromboembolic conditions is leading to more diagnoses, which in turn increases the patient population that might be prescribed Eliquis.
- Healthcare Expenditure and Access to Medications: Rising healthcare expenditures and the increasing availability of medications in various markets facilitate greater access to Eliquis.
- Market Exclusivity and Patent Protection: The patent protection of Eliquis (apixaban) limits generic competition, allowing for sustained revenue generation for the manufacturer, Bristol-Myers Squibb and Pfizer.
- Partnerships and Marketing Strategies: Effective marketing strategies and partnerships between pharmaceutical companies and healthcare providers can enhance the visibility and market penetration of Eliquis.
- Expansion to New Markets: The introduction of Eliquis in emerging markets with growing healthcare infrastructure may also drive market growth.
- Regulatory Approvals for New Indications: Any new approvals for additional indications or combinations, as well as ongoing research and development, may further expand the use of Eliquis and prompt growth in the market.
Global Eliquis Market Restraints
The market for Eliquis (apixaban), a direct oral anticoagulant used primarily for preventing and treating thromboembolic disorders, faces several restraints that can affect its growth and market penetration. Here are some of the key market restraints:
- Generic Competition: The expiration of patent protection for Eliquis may lead to the availability of generic alternatives, which could significantly impact Eliquis’s market share and pricing.
- Regulatory Challenges: The approval of drugs in the anticoagulant class often involves rigorous regulatory scrutiny. Any delays or challenges in obtaining approval for new formulations or indications can restrain market growth.
- Adverse Effects and Safety Concerns: As with any medication, the risk of side effects, such as bleeding complications, may lead to patient reluctance and could hinder the drug’s adoption among healthcare providers.
- High Cost: Eliquis is relatively expensive compared to some traditional anticoagulants. This high cost may limit its accessibility, particularly in regions with less healthcare funding or among uninsured patients.
- Market Saturation: The anticoagulant market is becoming increasingly crowded, with multiple competing products available. This saturation can dilute Eliquis’s market share and lead to price competition.
- Patient Adherence: The need for ongoing therapy and the potential for side effects may affect patient adherence to Eliquis, impacting overall market demand.
- Healthcare Provider Preferences: Some healthcare professionals may prefer alternative therapies or generic options, impacting the prescribing behavior for Eliquis.
- Formulary Restrictions: Health insurance formulary restrictions or the preference for cheaper alternatives may limit Eliquis’s prescription rates among insured patients.
- Emerging Novel Therapeutics: New and emerging anticoagulant therapies that offer better safety profiles, dosing convenience, or efficacy may pose a competitive threat to Eliquis.
- Economic Recession and Budget Constraints: Economic downturns or increased healthcare costs can lead to tighter healthcare budgets, which may impact the utilization of branded medications like Eliquis.
Global Eliquis Market Segmentation Analysis
The Global Eliquis Market is Segmented on the basis of Indication, End-User, Distribution Channel and Geography.
Eliquis Market, Indication
- Atrial Fibrillation
- Deep Vein Thrombosis
- Pulmonary Embolism
The Eliquis Market is a vital segment within the anticoagulant medication landscape, primarily focusing on preventing thrombosis and managing various cardiovascular conditions. Eliquis, which is the trade name for apixaban, is a direct oral anticoagulant (DOAC) widely prescribed for several indications. The primary subsegments of the Eliquis Market include atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE), each representing distinct clinical needs among patients. Atrial fibrillation is a common heart rhythm disorder that significantly increases the risk of stroke; Eliquis serves as a crucial therapeutic option, providing effective stroke prevention by inhibiting factor Xa, a key protein in the blood coagulation pathway.
The deep vein thrombosis subsegment is pivotal, as DVT represents a serious condition characterized by the formation of blood clots in the deep veins, typically in the legs, which can lead to severe complications. Eliquis is effective in both the treatment and prevention of DVT recurrence. The pulmonary embolism segment is equally important; PE occurs when a blood clot travels to the lungs, leading to potentially life-threatening complications. Eliquis is indicated for treating and preventing PE, thus offering significant therapeutic benefits to this patient group. Each of these subsegments addresses unique patient populations and treatment protocols, highlighting the comprehensive role of Eliquis in the management of various thromboembolic conditions, ensuring its position as a cornerstone in contemporary anticoagulation therapy.
Eliquis Market, End-User
- Hospitals
- Outpatient clinics
- Pharmacies
The Eliquis Market, a crucial segment within the pharmaceutical landscape focused on anticoagulants, is primarily categorized by its end-users, which play a significant role in determining the drug’s distribution and utilization dynamics. Key end-user segments include hospitals, outpatient clinics, and pharmacies, each serving distinct patient care functions that influence the overall reach of Eliquis. Hospitals are significant end-users, as they administer this potent anticoagulant for managing conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism in acute care settings. The inpatient environment allows for close monitoring and immediate response to any adverse reactions, essential for such high-risk medications. Outpatient clinics represent another vital subsegment, as they provide a continuum of care for patients transitioning from hospital stays or those managing chronic conditions.
These clinics enable healthcare providers to monitor patients in a less intensive setting while maintaining oversight on their anticoagulation therapies. Lastly, pharmacies constitute the final subsegment, playing a pivotal role in community settings where patients fill prescriptions for Eliquis. Community pharmacies enhance accessibility and patient awareness regarding the medication, often providing counseling and support for adherence to therapy. The intricate interplay among these subsystems highlights the diverse pathways through which Eliquis can reach patients, emphasizing the importance of targeted market strategies to optimize therapeutic outcomes and drive overall market growth. By understanding the specific needs and roles of each end-user, stakeholders can better position Eliquis within the healthcare continuum, ultimately enhancing patient care and engagement.
Eliquis Market, Distribution Channel
- Retail pharmacies
- Hospital pharmacies
- Online pharmacies
The Eliquis Market, a vital segment of the pharmaceutical industry, is categorized based on distribution channels, which play an essential role in making this anticoagulant medication widely accessible to patients. The main market segment under consideration is the distribution channel, which comprises several subsegments including retail pharmacies, hospital pharmacies, and online pharmacies. Retail pharmacies serve as a primary point of access for many patients, providing Eliquis to individuals seeking treatment for conditions such as atrial fibrillation or venous thromboembolism. These establishments facilitate easy customer interaction and often engage in patient education regarding medication adherence and management. Hospital pharmacies, on the other hand, focus on inpatient care, where Eliquis is dispensed to hospitalized patients who require anticoagulation therapy under the supervision of healthcare professionals.
The facility-based nature of hospital pharmacies ensures immediate availability for critical interventions but also requires stringent monitoring to manage potential side effects and drug interactions. Finally, online pharmacies represent an increasingly popular subsegment, characterized by their convenience and accessibility, allowing patients to order Eliquis from the comfort of their homes. This channel often enhances medication adherence by offering refills and reminders, catering particularly to patients with mobility challenges or those residing in rural areas. Each of these subsegments contributes uniquely to the overall Eliquis Market, reflecting varying patient needs and preferences while collectively facilitating comprehensive anticoagulation management across diverse healthcare settings.
Eliquis Market, By Geography
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
The Eliquis Market, a leading anticoagulant used for conditions such as atrial fibrillation and venous thromboembolism, is segmented geographically, reflecting the diverse healthcare landscapes, prescription practices, and regulatory environments across regions. In North America, primarily driven by the United States and Canada, the Eliquis Market benefits from high healthcare expenditure, advanced healthcare infrastructure, and a growing aging population, which increases the prevalence of conditions requiring anticoagulation therapy. Furthermore, extensive insurance coverage and strong awareness regarding new therapeutic options enhance its uptake.
In Europe, the market dynamics are influenced by varying healthcare policies, regulatory approvals, and the presence of alternative anticoagulants. Countries like Germany, France, and the UK exhibit robust adoption rates due to national health systems prioritizing effective cardiovascular treatments, though disparities in market penetration exist among member states. The Asia-Pacific region presents a rapidly growing opportunity for the Eliquis Market, characterized by an increasing burden of life-style-related diseases, rise in healthcare spending, and improving access to advanced medications. Countries such as China and India are witnessing a significant uptick in demand as healthcare systems evolve. In the Middle East and Africa, the Eliquis Market faces challenges such as limited healthcare resources and lower awareness levels, but there remains considerable potential as healthcare investments rise. Efforts to expand medication access and public health initiatives aimed at educating risk populations could foster market growth. Collectively, these geographic segments highlight the dynamic landscape and varying growth drivers across the Eliquis Market globally.
Key Players
The major players in the Eliquis Market are:
- BristolMyers Squibb
- Pfizer
- Mylan (now part of Viatris)
- Teva Pharmaceuticals
- Sandoz (a Novartis division)
- Amgen
Report Scope
[vmrrepetersegdetailstableshortcode]
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as noneconomic factors
• Provision of market value (USD Billion) data for each segment and subsegment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes indepth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6month postsales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
[vmr_faqtagshortcode]
Frequently Asked Questions
1. Introduction
• Market Definition
• Market Segmentation
• Research Methodology
2. Executive Summary
• Key Findings
• Market Overview
• Market Highlights
3. Market Overview
• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter’s Five Forces Analysis
4. Eliquis Market, By Indication
• Atrial Fibrillation
• Deep Vein Thrombosis
• Pulmonary Embolism
5. Eliquis Market, By End-User
• Hospitals
• Outpatient clinics
• Pharmacies
6. Eliquis Market, By Distribution Channel
• Retail pharmacies
• Hospital pharmacies
• Online pharmacies
7. Regional Analysis
• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE
8. Competitive Landscape
• Key Players
• Market Share Analysis
9. Company Profiles
• Bristol-Myers Squibb
• Pfizer
• Mylan (now part of Viatris)
• Teva Pharmaceuticals
• Sandoz (a Novartis division)
• Amgen
10. Market Outlook and Opportunities
• Emerging Technologies
• Future Market Trends
• Investment Opportunities
11. Appendix
• List of Abbreviations
• Sources and References
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
